23 August 2023 - The Federal Ministers give a final decision (positive with conditions) for this trial
Trial reference:
A two-part, open-label systemic gene delivery study to evaluate the safety and expression of RO7494222 (SRP-9001) in subjects under the age of four with Duchennne Muscular Dystrophy (ENVOL)